As China’s markets rally, will investors take the plunge?
A mix of US rate cuts and Chinese policies triggered rallies across A-shares, Hong Kong stocks, and US-listed Chinese companies,
All posts by 36Kr English
Read More »
36Kr English
01:20
ePropulsion’s electric motors are making waves in Europe’s boating industry
From China to Europe, the Chinese electric motor manufacturer is charting a course to lead the electric boating market. The
36Kr English
07:38
Anta Sports and Kyrie Irving’s father team up to conquer Western markets
Anta Sports partners with Kyrie Irving’s father to launch the Kai 1 Speed, making a bold push into Foot Locker
36Kr English
06:26
Can prioritizing China reverse the ailing fortunes of luxury car giants BBA?
Audi partners with SAIC under a new China-focused model to build EVs, echoing a broader shift among global automakers. The
36Kr English
06:26
Zhuanzhuan’s takeover of Plum adds to China’s consolidation wave as venture capital cools
Secondhand luxury platform Plum is the latest to fold into a bigger player as China’s consumer investment dries up. The
36Kr English
05:26
Xpeng ramps up production as Mona M03 orders surpass expectations
Xpeng Motors is racing to meet demand for its Mona M03 after orders exceeded 100,000 units. The post Xpeng ramps
36Kr English
05:26
ByteDance enters AI video race with Doubao’s PixelDance and Seaweed
Months after Kuaishou’s Kling AI launched to much acclaim, ByteDance has followed up with two new AI video generation models.
36Kr English
03:24
With RMB 320 billion in sales, Douyin’s life services business still faces uphill growth battle
After a strong start in 2024, Douyin’s life services business faces new challenges in maintaining its momentum. The post With
36Kr English
09:22
Why China is betting on V2G to stabilize its overworked power grid
China is pushing to expand vehicle-to-grid technology, turning electric cars into mobile power banks, but challenges loom large. The post
36Kr English
07:28
Can gene therapy live up to the hype? A look at China’s Exegenesis Bio
Founder Wu Zhenhua explores the promise of gene therapy and its potential to reshape the future of medicine. The post
